Validation of Quantitative Imaging Biomarkers The FDA makes a distinction between white-listing (approval or clearance) of a diagnostic drug or device for commercial purposes and qualification of a measurement itself to be used as a biomarker in clinical trials. Approval is only available after demonstrating the safety and effectiveness of a device or drug. However,…… Read More »